Alicia Little is a Dermatology physician affiliated with Yale University. OpenAlex indexes 45 publications with 822 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
333 Cedar St, Dermatology
New Haven, CT 065208059
Telephone
203-785-4092Provider last certified this registry record 22 Jan 2021.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- LEO Pharma ASProgram year20251 payment
- LEO Pharma Inc.Program year20251 payment
- PFIZER INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
39.7%Interleukin-4 Receptor alpha Antagonist20.4%Dupixent Pen100%Part D<11 patientsPolyene Antifungal12.6%Nystatin100%Part D≥27 patients+ 1 more class in this area
Anti-infectives
23.7%Azole Antifungal16.5%Ketoconazole100%Part D≥24 patientsNitroimidazole Antimicrobial7.3%Metronidazole100%Part D<11 patientsSensory organs
20.9%Corticosteroid20.9%Clobetasol Propionate80%Hydrocortisone20%Part D≥36 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2023–2026 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Treatment Utilization Patterns in Cutaneous Lupus Erythematosus: A Single-Center Retrospective Analysis
Journal of the American Academy of Dermatology
2026 - Acitretin and methotrexate in vulvar lichen sclerosus
Journal of the American Academy of Dermatology
2026 - Challenges in the transition to independent dermatology practice: prevalence of impostor phenomenon and a needs assessment of professional skills
International Journal of Women’s Dermatology
2026 - Cutaneous Lupus Features Specialized Stromal Niches and Altered Retroelement Expression
Journal of Investigative Dermatology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
John Krystal, MD
Yale University
Lajos Pusztai, MD
Yale University
Lee Schwamm, MD
Yale University
Naftali Kaminski, MD
Yale University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”